A combination of 3 antiviral drugs appears to show some promise in treating COVID-19, the respiratory illness caused by the novel coronavirus, Reuters reports. However, the results of the small study are preliminary and must be considered in the context of multiple other studies that have been considered as a treatment for the deadly pandemic.
A study of 127 patients, sickened with COVID-19, in Hong Kong saw two groups of test subjects treated side-by-side for comparison. One group, a test group, was given a combination of three drugs: lopinavir–ritonavir, which is used to treat HIV/AIDS; ribavirin, which treats hepatitis; and interferon beta, which treats multiple sclerosis. A control group was given only the HIV medicine.
0 comments :
Post a Comment